Genomic rearrangements that create cell-type-specific fusion oncogenes are hallmarks of cancer 1,2 . The crucial step for development of such genomic rearrangements is the generation of DNA DSBs and subsequent illegitimate repair of these breaks 3, 4 . However, the factors that are involved in DSB genesis and the mechanisms that produce celltype-specific genomic rearrangements are not well understood for most malignancies. In human prostate cancer, a number of recurrent rearrangements involving various androgen receptor target genes fused to oncogenic transcription factors of the ETS family have been described 5 . The most common of these rearrangements, occurring in nearly 50% of prostate cancers, involves fusion of TMPRSS2, an androgen regulated gene, with ERG, an ETS transcription factor gene, resulting in activation of the TMPRSS2-ERG fusion oncogene through subversion of androgen signaling 5, 6 . Given the high prevalence of prostate cancer in the population 7 and the high fraction of prostate cancers harboring this fusion oncogene 5 , the TMPRSS2-ERG gene fusion is the most common fusion gene observed in any human cancer. However, the mechanisms involved in generating the DSB that leads to these TMPRSS2-ERG rearrangements are not completely understood.
A r t i c l e s
Genomic rearrangements that create cell-type-specific fusion oncogenes are hallmarks of cancer 1, 2 . The crucial step for development of such genomic rearrangements is the generation of DNA DSBs and subsequent illegitimate repair of these breaks 3, 4 . However, the factors that are involved in DSB genesis and the mechanisms that produce celltype-specific genomic rearrangements are not well understood for most malignancies. In human prostate cancer, a number of recurrent rearrangements involving various androgen receptor target genes fused to oncogenic transcription factors of the ETS family have been described 5 . The most common of these rearrangements, occurring in nearly 50% of prostate cancers, involves fusion of TMPRSS2, an androgen regulated gene, with ERG, an ETS transcription factor gene, resulting in activation of the TMPRSS2-ERG fusion oncogene through subversion of androgen signaling 5, 6 . Given the high prevalence of prostate cancer in the population 7 and the high fraction of prostate cancers harboring this fusion oncogene 5 , the TMPRSS2-ERG gene fusion is the most common fusion gene observed in any human cancer. However, the mechanisms involved in generating the DSB that leads to these TMPRSS2-ERG rearrangements are not completely understood.
Dysfunction of topoisomerase II (TOP2), an enzyme that catalyzes a transient DSB to resolve DNA topological constraints, can produce DSBs that have been implicated in the pathogenesis of rearrangements in treatment-related acute myeloid leukemia (t-AML) and childhood leukemias [8] [9] [10] [11] . Estrogen receptor signaling has been reported to recruit the TOP2 isoform TOP2B to regulatory regions of estrogen receptor target genes, leading to TOP2B-mediated DSBs 12 . We hypothesized that androgen receptor signaling might lead to TOP2B-mediated DSBs and that such breaks could be involved in the generation of recurrent TMPRSS2-ERG rearrangements in prostate cancer.
We show that androgen signaling leads to co-recruitment of androgen receptor and TOP2B and to TOP2B-mediated DSBs at regulatory regions of androgen receptor target genes, as well as at regions of the TMPRSS2 and ERG loci that were highly aligned with genomic breakpoints of TMPRSS2-ERG fusion genes in prostate cancer. These androgen-induced TOP2B-mediated DSBs were highly recombinogenic and could lead to de novo production of TMPRSS2-ERG fusion transcripts in a TOP2B-dependent manner. In human prostate tissue, androgen receptor and TOP2B, which were rarely both present in normal TMPRSS2-ERG fusion-negative prostate cells at high levels, were both robustly coexpressed in TMPRSS2-ERG fusion-positive neoplastic cells comprising prostatic intraepithelial neoplasia (PIN) lesions, known precursors to prostate cancers. These findings implicate androgen receptor signaling and TOP2B action in the generation of TMPRSS2-ERG rearrangements. The occurrence of TOP2B-mediated DSBs during regulated transcription represents a new paradigm for the development of DSBs involved in generating gene rearrangements in cancer.
RESULTS

TOP2B is required for androgen-mediated gene expression
We used the LNCaP and LAPC4 prostate cancer cell lines, which have intact androgen signaling ( Supplementary Fig. 1 ) but do not harbor TMPRSS2-ERG rearrangements, to investigate whether A r t i c l e s TOP2B is required for efficient activation of androgen receptor target genes in androgendeprived cells stimulated with the prototypical androgen dihydrotestosterone (DHT). By genome-wide gene expression microarray analysis, we found that pharmacological inhibition (with etoposide or merbarone) or depletion of TOP2B by RNA interference (RNAi) (sh-TOP2B) coordinately attenuated the upregulation of DHT-induced genes. This finding was confirmed by quantitative RT-PCR of candidate genes in both LNCaP and LAPC4 cells ( Fig. 1 and Supplementary Figs. 1-3) . Gene set enrichment analysis 13, 14 revealed that androgen-induced transcriptional programs were enriched for downregulation by TOP2 inhibition (P < 10 −14 ) or sh-TOP2B (P < 10 −2 ) compared to all other genes (Fig. 1a,b and Supplementary Figs. 2 and 3) . These analyses show that both pharmacological and genetic modulations of TOP2B lead to concordant downregulation of androgen receptor-regulated genes.
TOP2B catalytic activity at androgen-receptor target genes
We next investigated whether TOP2B was directly involved in DHTinduction of androgen receptor target genes. Chromatin immunoprecipitation (ChIP) experiments revealed coordinate recruitment of both androgen receptor and TOP2B to the enhancer and promoter regions of KLK3 (which encodes the prostate specific antigen, PSA) and TMPRSS2 in DHT-treated cells. This coordinate recruitment at regulatory regions seemed to be fairly specific as our ChIP assay did not show recruitment to the 'middle' region of KLK3 or to regulatory regions of other arbitrarily selected genes (Fig. 2a,b and Supplementary Fig. 4 ). Androgen receptor and TOP2B are recruited to these regulatory regions as part of a complex, as stimulation with DHT resulted in coimmunoprecipitation of TOP2B and androgen receptor (Fig. 2c) and co-recruitment of TOP2B and androgen receptor to androgen-responsive elements (AREs) of KLK3 and TMPRSS2 in ChIP-re-ChIP experiments (Fig. 2d) . This androgen receptor-TOP2B complex formation did not depend on the presence of DNA, as pretreatment of lysates with DNAseI or excesses of ethidium bromide did not significantly disrupt complex formation ( Supplementary Fig. 4 ). To ascertain whether TOP2B was catalytically cleaving genomic DNA at regulatory regions of KLK3 and TMPRSS2, we conducted a potassium SDS (KSDS) assay 15 , which allows etoposide-stabilized TOP2 catalytic cleavage complexes to be isolated. This showed robust TOP2 cleavage at the KLK3 enhancer and promoter and the TMPRSS2 enhancer but not at regions that did not contain androgen receptor or TOP2B binding sites ( Fig. 2e and Supplementary Fig. 5 ). This activity was abolished by short interfering (si)-TOP2B treatment before DHT stimulation ( Fig. 2f and Supplementary Fig. 6 ), indicating that the catalytic activity was mediated by TOP2B.
TOP2B catalytic cleavage near TMPRSS2-ERG breakpoints
As TOP2 cleavage can produce fragile sites for development of DSBs leading to genomic rearrangements in other malignancies [8] [9] [10] [11] , we hypothesized that androgen-mediated TOP2 catalytic cleavage at key sites within TMPRSS2 and/or ERG might create DSBs and TMPRSS2-ERG genomic rearrangements in prostate cancer. Examination of previously published datasets revealed that genomic breakpoints in TMPRSS2 and ERG occur most frequently at the ~25-kb region between exon 1 and exon 4 of TMPRSS2 and at a ~75-kb stretch in intron 3 of ERG [16] [17] [18] (Supplementary  Table 1 ). We identified breakpoints at high resolution in eight cases described in these previous reports, and we sequenced the TMPRSS2 and ERG genomic breakpoints to nucleotide resolution in three of these cases (Fig. 3a, Supplementary Fig. 7 and Supplementary Table 1). We used the KSDS assay and tiled 71 real-time PCR amplicons across the ~100 kb surrounding the TMPRSS2 and ERG genomic segments that showed hotspots for breakpoints, and found regions with high levels of DHT-induced A r t i c l e s TOP2 cleavage that were significantly enriched for proximity to TMPRSS2 (P = 0.010) and ERG (P = 0.013) breakpoints (Fig. 3a) .
When we examined the breakpoints of two of the three subjects (cases 24 and 30) for whom we sequenced rearrangement junctions, we found that the TMPRSS2 and ERG breakpoints seen in these cases were aligned with DHT-induced, TOP2B-mediated cleavage sites in LAPC4 cells ( Fig. 3b and Supplementary Fig. 8 ). To verify this association, we developed a novel assay for selective labeling of TOP2 cleavage sites (SLOT), which allows specific labeling of the etoposidestabilized TOP2-DNA cleavage complex (Supplementary Figs. 9 and 10). Using SLOT, we observed strong enrichment for DHT-dependent TOP2 cleavage at the NspI restriction fragment closest to the precise TMPRSS2-ERG genomic breakpoint observed in cases 24 and 30 ( Fig. 3c and Supplementary Fig. 8 ).
Androgen receptor binds specifically to thousands of genomic sites, even if those sites lack canonical AREs 19 . As the sites that showed high DHT-induced TOP2B cleavage within the TMPRSS2 and ERG genes did not contain known AREs, we carried out ChIP experiments to understand whether TOP2 cleavage at these sites was a consequence of such non-canonical DHT-induced androgen receptor recruitment. As expected, all of the sites that showed high TOP2 cleavage (for example, T8, T6, E5, E13, E28; Fig. 3a) showed DHT-induced co-recruitment of both TOP2B and androgen receptor (1.5-15-fold over control; Fig. 3d ), suggesting direct androgen-induced androgen receptor-coupled TOP2B recruitment to these sites, whereas sites that did not show strong TOP2B cleavage (for example, T23, E47, E35) showed weak or absent recruitment of both TOP2B and androgen receptor ( Supplementary Fig. 11 ).
In further support of the idea that these intragenic androgen receptor-TOP2B target sites have a DHT-induced regulatory role, a representative site, T8, showed a specific DHT-induced chromatin interaction with both the enhancer and promoter of TMPRSS2 in chromosome conformation capture (3C) experiments (Fig. 3e,f and Supplementary Fig. 12 ) 20 . Consistent with the hypothesis that recruitment and activity of TOP2B at these sites is required for assembly of these enhancer-and promoter-T8 chromatin complexes, treatment of androgen-deprived LAPC4 cells with merbarone before stimulation with DHT abolished the formation of these complexes. We speculate that TOP2B activity allows resolution of topological entanglements created during the formation of these transcriptionassociated chromatin loops.
TOP2B-mediated DSBs are recognized by the repair machinery
We next tested whether sites that showed DHT-induced androgen receptor-TOP2B recruitment and TOP2B catalytic cleavage could be fragile sites for persistent DSB formation. We found that stimulation with DHT could induce widespread formation of γH2A.X foci (Fig. 4a) , which form around DSBs 21 . We also observed pronounced ATM recruitment, a central feature of DSB repair pathways 22, 23 , to sites showing strong androgen receptor-TOP2B recruitment and TOP2B catalytic activity (KLK3 enhancer and promoter, regions T6, T8, T20, E5, E13 and E28), but much less so to a region in ERG (E35) that did not show significant TOP2 catalytic activity ( Fig. 4b and Supplementary Fig. 13 ).
To detect DSBs at relevant sites directly, we labeled these breaks with biotin-conjugated nucleotides in situ using terminal DNA transferase 12 (Supplementary Fig. 13 ). In parallel with ATM recruitment, DHT induced DSBs at sites of TOP2B recruitment/catalytic activity and androgen receptor binding within the TMPRSS2 and ERG genes ( Fig. 4c,d ). Conversely, regions in KLK3 and ERG that did not show significant TOP2B catalytic activity (middle, E35) did not show significant DSB formation (Fig. 4d) . DSBs and ATM recruitment appeared within the first 6 h after DHT stimulation and largely resolved after 24 h (Fig. 4e and Supplementary Fig. 13 ). ChIP-re-ChIP A r t i c l e s experiments showed recruitment of ATM to the biotin-labeled strand breaks, indicating that these breaks were truly DSBs and not just single-strand nicks (Fig. 4f,g) . A ligation-mediated PCR (LM-PCR) method allowed single nucleotide mapping of breaks that occurred at a representative region with high DHT-induced TOP2B enrichment/catalytic cleavage, ATM recruitment and close alignment to a TMPRSS2 genomic breakpoint in a clinical prostate cancer case (region T6; Supplementary Fig. 14) . This provided further direct evidence of DSBs at these sites. TOP2B was also present at these biotin-labeled DSBs in ChIP-re-ChIP experiments, pointing to its involvement in generating these breaks ( Fig. 4g and Supplementary  Fig. 13 ). In support of this, RNAi-mediated depletion of TOP2B or androgen receptor (sh-AR) significantly reduced formation of biotinlabeled strand breaks ( Fig. 4f and Supplementary Fig. 13 ).
To investigate whether these DSBs could result in genomic breaks and/or chromosomal rearrangements at an individual cell level, we performed dual-color fluorescence in situ hybridization (FISH) assays with a pair of probes flanking the TMPRSS2 or ERG genes ( Supplementary  Fig. 15) . A significant separation, or 'split-apart' , of these probes would indicate the presence of a genomic break or rearrangement in the intervening genomic sequence. As a positive control, we treated LAPC4 cells with etoposide, a known TOP2-dependent genomicbreak-inducing agent. This resulted in generation of split-aparts at the TMPRSS2 and ERG loci in ~16% and ~8% of cells, respectively (Fig. 4h,i) . Stimulation of LAPC4 and LNCaP cells with DHT alone resulted in a significant increase in genomic breaks in TMPRSS2 compared to unstimulated cells ( Fig. 4h and Supplementary Fig. 16) . Similarly, stimulation with DHT followed by treatment with etoposide showed increased split-aparts at both the TMPRSS2 and ERG loci compared to control LNCaP and LAPC4 cells or cells treated with DHT alone or etoposide alone (Fig. 4h,i and Supplementary  Fig. 16 ). This DHT-induced increase in split-aparts was significantly attenuated by si-TOP2B (Supplementary Fig. 16 ). These data suggest that DHT stimulation could cooperate with TOP2B action to induce genomic breaks and/or chromosomal rearrangements at these loci.
TOP2B-mediated double strand breaks are recombinogenic
We devised an androgen-induced genomic recombination assay to assess whether these androgen-induced TOP2B-mediated DSBs were competent recombination foci, and whether these breaks could significantly increase genomic recombination events at these sites. For this assay, we cloned a region showing high DHT-induced TOP2B catalytic activity (T8 in intron 1 of TMPRSS2) and one showing low TOP2B catalytic activity (TMPRSS2 exon 6; Fig. 5a ) into a plasmid vector containing a blasticidin-resistance gene to create the pcDNA6. 
(a) Sites closest to TMPRSS2-ERG breakpoints from eight
A r t i c l e s of these constructs into LAPC4 cells followed by stimulation with DHT led to increased formation of biotin-labeled DSBs in the IN-1 insert, but not the EX-6 insert (Fig. 5b) . To assess whether these DHTinduced breaks increased recombination efficiency, we transfected the IN-1 or EX-6 constructs along with control or sh-TOP2B constructs into LAPC4 cells, depleted the media of androgens, stimulated the cells with DHT for 24 h to induce DSB formation, split the cells to clonogenic density, and subjected them to blasticidin selection in androgen-containing media for 2 weeks. The number of colonies formed after 14 days would indicate the number of successful recombination events that allowed incorporation of blasticidin-resistance vectors into genomic DNA (Fig. 5c) . Consistent with our hypothesis, the IN-1 vector produced significantly more colonies than the EX-6 construct, and this increased frequency was abolished by sh-TOP2B (Fig. 5d,e) . Transfection of LAPC4 cells with sh-TOP2B alone without blasticidin selection did not decrease clonogenic survival compared to control transfected cells (Supplementary Fig. 17 ). Furthermore, both plasmids were equally competent in producing recombination events if they were linearized with a restriction enzyme before transfection (Supplementary Fig. 18 ). In addition, a ligation-mediated PCR strategy showed that the increased frequency of recombination in the IN-1 construct was due to recombination events occurring in the insert and not non-specifically at the vector backbone (Fig. 5f) . These data provide evidence that DHT-induced TOP2B-mediated DSBs at target sites can promote genomic recombination of these target sites. We next assessed whether DHT-induced TOP2B-mediated DSBs can result in production of de novo TMPRSS2-ERG fusion genes in LNCaP and LAPC4 cells. We developed a highly sensitive RT-PCR assay that can detect fusion transcripts juxtaposing exon 1 of TMPRSS2 with exon 4 of ERG, at a frequency of ~1 in 10 8 cells (Supplementary  Fig. 19 ). As LAPC4 and LNCaP cells do not harbor TMPRSS2-ERG genomic rearrangements, the low level of TMPRSS2-ERG fusion transcripts seen when these cells were maintained in their fully supplemented, androgen-containing media (steady state) or when grown in androgen-depleted media (control) represents the background level for this sensitive assay. In four independent experiments involving two different cell lines, DHT stimulation of LAPC4 or LNCaP cells led to increased de novo production of TMPRSS2-ERG fusion transcripts (Fig. 5g,h and Supplementary Fig. 19) . Pharmacological inhibition or RNAi-mediated depletion of TOP2B, or of the DSB repair pathway components PARP1 or DNA-PK CS , before stimulation of LAPC4 cells with DHT resulted in complete reduction of de novo TMPRSS2-ERG fusion transcript formation back to background levels (Fig. 5g) .
TOP2B and androgen receptor are highly coexpressed in PIN
The TMPRSS2-ERG rearrangements are known to occur as early as the PIN prostate cancer precursor lesions 24 and are probably selected A r t i c l e s for during the formation of invasive adenocarcinoma 5, 25 . We carried out FISH and coimmunostaining of androgen receptor and TOP2B in PIN and matched normal prostatic tissue. In agreement with previous studies 24, 25 , 10 of 23 subjects with PIN and none of the matched benign prostate tissues showed TMPRSS2-ERG rearrangement as determined by TMPRSS2 FISH (Fig. 6a,b and Supplementary Tables 2 and 3) . Basal cells in the normal prostate glands showed much stronger staining for TOP2B than the luminal cells (Fig. 6c) . By contrast, the luminal cells in normal glands showed much stronger staining for androgen receptor than the basal cells (Fig. 6c) . However, TOP2B staining became more promiscuous in PIN, with luminal cells expressing nearly as much TOP2B as basal cells in these lesions. Androgen receptor continued to be highly expressed in PIN luminal cells, creating a more pronounced coexpression of both TOP2B and androgen receptor in these cells ( Fig. 6d and Supplementary Table 3 ). This increased coexpression of TOP2B and androgen receptor might predispose PIN luminal cells to develop the androgen receptor-and TOP2B-mediated DSBs that are found in DHT-stimulated LNCaP and LAPC4 cells.
DISCUSSION
These data suggest a model in which intrinsic androgen signaling in neoplastic prostate cells induces TOP2B-mediated DSBs at many genomic loci, including breakpoints of TMPRSS2-ERG rearrangements in prostate cancer, even without extrinsic DSB-inducing genotoxic stress. These androgen-induced TOP2B-dependent DSBs can participate in genomic recombination events and can generate rare TMPRSS2-ERG gene rearrangements (Fig. 7) . Another report has suggested that in the presence of high levels of exogenous genotoxic stress, other enzymes such as activation-induced cytidine deaminase (AID) and LINE-1 repeat-encoded ORF2 endonuclease can cooperate with androgen receptor signaling to establish DSBs and, ultimately, prostate cancer gene rearrangements 26 . Together, the data from the current study and this previous report indicate that multiple enzymatic activities, including that of TOP2B in the case of intrinsic androgen signaling (current study) and that of other nucleases in the case of exogenous genotoxic stress 26 , can cooperate with androgen signaling to generate recombinogenic DSBs and TMPRSS2-ERG rearrangements. Although the biochemical mechanisms by which TOP2B can mediate generation of frank DSBs are not well understood, a number of hypotheses can be drawn from previous studies. First, reactive oxygen species, such as those elaborated by androgen signaling in prostate cells in vitro 27 , or the inflammatory milieu often seen surrounding prostate preneoplastic lesions in vivo 28 , can stabilize TOP2-DNA cleavable complexes 29 . Dietary constituents, such as various bioflavonoids, can A r t i c l e s also stabilize TOP2-DNA cleavable complexes 11 . These stabilized cleavable complexes can be converted to overt DSBs by proteasomal degradation of TOP2B 30 or by collision with replication or transcriptional machinery 31 . These hypotheses might help to explain the epidemiological evidence that links pro-oxidant stress, inflammation and dietary factors in the etiology of prostate cancer 28, 32 . Indeed, the relatively high rate at which we observed genomic breaks in PIN cells and in androgen-stimulated LAPC4 and LNCaP cells might reflect somewhat dysregulated androgen signaling, which is known to promote both caricaturized differentiation and proliferation/survival pathways in these cells 33, 34 . Owing to androgen-induced increases in both proliferation and transcription in these cells, such dysregulation of androgen signaling could cause increased rates of collision between transcription or replication forks and androgen-induced TOP2B cleavable complexes, with resultant DSB formation. By contrast, androgen signaling in normal cells induces terminal differentiation with suppression of proliferation, a state that might be largely resistant to the generation of genomic breaks and rearrangements 35 . Furthermore, as DNA damage-sensing pathways are likely to be functional in normal cells, even if rare breaks occur in such cells, they are likely to undergo senescence, cell death or appropriate repair 36 . However, if a rare genomic error leading to rearrangement of the TMPRSS2 and ERG loci does occur, then this event is likely to become subject to strong selection 5, [37] [38] [39] . That these illegitimate repair events might be extremely rare and subject to selection helps to explain the observation that fusions of TMPRSS2 with ERG or other ETS family transcription factors are mutually exclusive 5 . If our model of androgen-induced TOP2B instability (TIN) (Fig. 7 ) during regulated transcription holds, we would predict that several different androgen receptor target genes should participate in genomic rearrangements in prostate cancer. In support of this, recent studies have shown rearrangements involving different androgen-induced genes, including TMPRSS2, KLK2, CANT1, SLC45A3, AX747630 and HERV-K_22q11. 23 (refs. 5,40) . Several of these androgen-induced fusion targets were modulated by TOP2B inhibition or depletion 
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Illegitimate recombination Figure 7 Proposed model for androgen-induced TOP2B-mediated double strand breaks and TOP2B instability (TIN) for the formation of TMPRSS2-ERG gene fusions. Androgen stimulation leads to co-recruitment of ligandbound androgen receptor and TOP2B to regulatory regions of androgenresponsive genes as well as to regions of TMPRSS2 and ERG genes that participate in genomic rearrangements. TOP2B catalytic activity and the associated DSB formation are required for efficient activation of androgenresponsive genes, and these DSBs are usually resolved shortly after induction. In some circumstances, stabilization of these TOP2B-mediated DSBs can lead to illegitimate recombination and rare rearrangements between TMPRSS2 or other androgen-responsive genes and ERG that are then subject to selection during neoplastic outgrowth.
A r t i c l e s ( Fig.1 and Supplementary Figs. 2-4) . These data suggest that androgen-induced TOP2B-mediated DSBs contribute to the prostate cancer specificity of TMPRSS2-ERG fusions. We speculate that androgen-induced TOP2B-mediated DSBs might cooperate with androgen-induced proximity of TMPRSS2 and ERG genes, as suggested previously 26, 41 , to confer this lineage specificity. In addition, given that other transcriptional processes, including ER-, RAR-, and AP1-mediated transcriptional programs, also seem to involve TOP2B activity and associated DSBs 12 , the TIN model might be generalizable to lineage-specific genomic rearrangements in other malignancies. Finally, we speculate that the TIN model might underlie some of the genomic instability and copy number alterations observed during cancer progression 42 .
METhODS
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